Literature DB >> 19896280

The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence.

Linda Vi1, Bing Siang Gan, David B O'Gorman.   

Abstract

Dupuytren's disease is a pathological condition of the palmar fascia characterized by the formation of contractile disease cords that result in permanent finger contracture. This condition is believed to progress from a myofibroblast-rich nodule in the early clinical stages of the disease to a contractile disease cord spanning a portion of the fascia, leading to contracture of one or more digits. The mechanism(s) by which this disease progresses from a nodule to a collagenous disease cord are poorly understood. Here, we discuss two possible models of disease progression. Firstly, disease progression might be mediated by the proliferation and outward migration of disease cells from within the nodule to populate the adjacent palmar fascia, resulting in a disease cord containing contractile cells derived from the nodule itself. Alternatively, nodular cells may secrete disease-associated factors into the surrounding extra-cellular matrix, thereby altering its composition and triggering quiescent, phenotypically normal cells in the adjacent palmar fascia to take on a proliferative and contractile phenotype. Based on the available evidence and the current state of knowledge of myofibroblast biology, we hypothesize that extra-cellular matrix interactions resulting in conversion of adjacent palmar fascia cells to a disease phenotype is more likely than cell migration from the nodule. Understanding the mechanisms of Dupuytren's disease progression will assist in the development of effective therapeutic interventions to address the high clinical recurrence rate of this condition. Crown Copyright (c) 2009. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19896280      PMCID: PMC5115910          DOI: 10.1016/j.mehy.2009.10.009

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  Surgical treatment of Dupuytren's disease.

Authors:  M E Jabaley
Journal:  Hand Clin       Date:  1999-02       Impact factor: 1.907

3.  A new approach to study fibroblast migration.

Authors:  Bhavani P Thampatty; James H-C Wang
Journal:  Cell Motil Cytoskeleton       Date:  2007-01

4.  Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia.

Authors:  R J Alioto; R N Rosier; R I Burton; J E Puzas
Journal:  J Hand Surg Am       Date:  1994-05       Impact factor: 2.230

5.  Pathogenesis of Dupuytren's contracture: a correlative clinical-pathological study.

Authors:  H F Chiu; R M McFarlane
Journal:  J Hand Surg Am       Date:  1978-01       Impact factor: 2.230

6.  Racial distribution of Dupuytren's disease in Department of Veterans Affairs patients.

Authors:  A P Saboeiro; J J Porkorny; S I Shehadi; K S Virgo; F E Johnson
Journal:  Plast Reconstr Surg       Date:  2000-07       Impact factor: 4.730

7.  Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.

Authors:  Ewa Maria Koźma; Krystyna Olczyk; Grzegorz Wisowski; Andrzej Głowacki; Rafał Bobiński
Journal:  J Biochem       Date:  2005-04       Impact factor: 3.387

8.  Expression of a novel gene, MafB, in Dupuytren's disease.

Authors:  Lucy C Lee; Andrew Y Zhang; Alphonsus K Chong; Hung Pham; Michael T Longaker; James Chang
Journal:  J Hand Surg Am       Date:  2006-02       Impact factor: 2.230

9.  Extracellular matrix alters PDGF regulation of fibroblast integrins.

Authors:  J Xu; R A Clark
Journal:  J Cell Biol       Date:  1996-01       Impact factor: 10.539

10.  Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.

Authors:  Raymond Tse; Jeffrey Howard; Yan Wu; Bing Siang Gan
Journal:  BMC Musculoskelet Disord       Date:  2004-11-12       Impact factor: 2.362

View more
  11 in total

1.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

Review 2.  Dupuytren's Disease: An Outcomes-Focused Update.

Authors:  Yasser H Almadani; Joshua Vorstenbosch; Johnny Ionut Efanov; Liqin Xu
Journal:  Semin Plast Surg       Date:  2021-07-06       Impact factor: 2.195

3.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

4.  Chaperonin containing T-complex polypeptide subunit eta is a potential marker of joint contracture: an experimental study in the rat.

Authors:  Ronghan He; Zhe Wang; Yunxiang Lu; Junqi Huang; Jianhua Ren; Kun Wang
Journal:  Cell Stress Chaperones       Date:  2015-07-30       Impact factor: 3.667

Review 5.  Anti-fibrotic actions of relaxin.

Authors:  C S Samuel; S G Royce; T D Hewitson; K M Denton; T E Cooney; R G Bennett
Journal:  Br J Pharmacol       Date:  2016-07-07       Impact factor: 8.739

6.  Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts.

Authors:  Christopher Bainbridge; Lars B Dahlin; Piotr P Szczypa; Joseph C Cappelleri; Daniel Guérin; Robert A Gerber
Journal:  Eur Orthop Traumatol       Date:  2012-03-06

7.  GLYCOSAMINOGLYCANS AND PROTEOGLYCANS IN PALMAR FASCIA OF PATIENTS WITH DUPUYTREN.

Authors:  Priscilla Carneiro Hirai Nascimento; Elsa Yoko Kobayashi; Luiz Guilherme de Saboya Lenzi; João Baptista Gomes Dos Santos; Helena Bonciani Nader; Flávio Faloppa
Journal:  Acta Ortop Bras       Date:  2016 Mar-Apr       Impact factor: 0.513

8.  Overexpression of chaperonin containing T-complex polypeptide subunit zeta 2 (CCT6b) suppresses the functions of active fibroblasts in a rat model of joint contracture.

Authors:  Xiaoyou Yi; Zhe Wang; Jianhua Ren; Ze Zhuang; Kaihua Liu; Kun Wang; Ronghan He
Journal:  J Orthop Surg Res       Date:  2019-05-09       Impact factor: 2.359

9.  Hyaluronic acid-curcumin conjugate suppresses the fibrotic functions of myofibroblasts from contractive joint by the PTGER2 demethylation.

Authors:  Dongjie Yu; Ze Zhuang; Jianhua Ren; Xuefeng Hu; Zhe Wang; Jieyu Zhang; Yuansen Luo; Kun Wang; Ronghan He; Yunbing Wang
Journal:  Regen Biomater       Date:  2019-04-22

10.  Matrix and cell phenotype differences in Dupuytren's disease.

Authors:  Marike M van Beuge; Evert-Jan P M Ten Dam; Paul M N Werker; Ruud A Bank
Journal:  Fibrogenesis Tissue Repair       Date:  2016-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.